neuro42 receives USD 5M for research on portable intraoperative MRI

neuro42, Inc. announced a $5 million grant from the National Institute of Health’s National Institute of Neurological Disorders and Stroke (NIH / NINDS) for research on Portable Intraoperative MRI for Neurosurgery. With the award, neuro42 aims to advance MRI emerging modalities, such as MRI compatible robotic systems, for effectively guiding interventional procedures in neurosurgery.

“neuro42 is actively leading the industry in innovating MRI capabilities to optimize patient outcomes and enhance physician experience in an open, minimal footprint set up for interventional, robotic assisted neurosurgery,” said Abhita Batra, Founder and Chief Strategy Officer of neuro42. “Expanding our clinical and research initiatives to now include the NIH / NINDS award is validating to our goal of enabling confirmatory and direct MRI guided interventions in brain biopsies, tumor resections, laser ablations and other robotic interventions with our MRI technology platform.”

neuro42 estimates a large market need for MRI interventions, including 80 thousand brain tumor cases detected and over 4 million in epilepsy and Parkinson’s disease cases in the US each year.

The research indicated in this press release was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number U44NS136026. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
MB Bureau